Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical IL-1Ra in healthy volunteers
NCT03383276Phase 1Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, single-arm trial of anakinra in blepharokeratoconjunctivitis (BKC), sponsored by Beijing Tongren Hospital. Primary endpoints: Corneal fluorescein staining at 3 days, Best corrected visual acuity at 3 days and 3 more. Status: unknown.
02
Drugs
anakinra
03
Conditions
blepharokeratoconjunctivitis (BKC)
Beyond the preview
Go deeper on NCT03383276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383276.